4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-059825
SVP Pharma Dev & Mfg Ops sold 5,117 shares at $25.07 ($128,283)
- SVP Pharma Dev & Mfg Ops acquired 17,300 shares (option exercise)
- SVP Pharma Dev & Mfg Ops acquired 22,417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hora Maninder · SVP Pharma Dev & Mfg Ops
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-06 | Exercise or conversion : show line 1 in the form | +5,117 | $10.69 | $54,701 | 63,350 | D |
| 2017-11-06 | Sale : show line 2 in the form | −5,117 | $25.07 | $128,283 | 58,233 | D |
| 2017-11-07 | Exercise or conversion : show line 3 in the form | +17,300 | $10.69 | $184,937 | 75,533 | D |
| 2017-11-07 | Exercise or conversion : show line 4 in the form | −17,300 | $25.51 | $441,323 | 58,233 | D |
| Open-market sales · 5,117 sh · avg $25.07 · $128,283 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-06 | Exercise or conversion : show line 5 in the form Stock Option | −5,117 | 17,300 | D |
| 2017-11-07 | Exercise or conversion : show line 6 in the form Stock Option | −17,300 | 0 | D |
Loading xslF345X03/doc4.xml…